ViewRay sets the price range for its pending initial public offering, which would fetch $52 million at the midpoint.
ViewRay today set the terms for its pending initial public offering, saying it plans to float 4 million shares at $12 to $14 apiece.
At the midpoint of the range, the MRI-guided radiation therapy maker's IPO would fetch $52 million.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1MxAszB
Cap comentari:
Publica un comentari a l'entrada